期刊
VACCINE
卷 36, 期 38, 页码 5692-5700出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.vaccine.2018.08.016
关键词
Toxoplasma gondii; Virus-like particles; Vaccine; Synergistic effects; Rhoptry protein 18; Microneme protein 8
资金
- Ministry of Health & Welfare, Republic of Korea [HI15C2928]
- National Research Foundation of Korea (NRF) [2018R1A2B6003535, 2018R1A6A1A03025124]
- Cooperative Research Program for Agriculture Science & Technology Development [PJ01320501]
- Rural Development Administration, Republic of Korea
- NIH/NIAID [AI105170, AI093772]
Toxoplasma gondii rhoptry protein 18 (ROP18) and microneme protein 8 (MIC8) are important invasion factors that mediate parasite multiplication. The main objective of this study was to determine the immunogenicity and efficacy by virus-like particle (VLP) vaccines of T. gondii ROP18 VLPs and MIC8 VLPs in combination or individuals. Mice were intranasally immunized with single ROP18 VLPs or MIC8 VLPs, or a combination of ROP18 VLP5 and MIC8 VLPs followed by challenge with T. gondii tachyzoites (GT1) through intraperitoneal injection or challenge with T. gondii (ME49) through oral infection. Vaccination with a combination of ROP18 VLPs and MIC8 VLP5 resulted in more potent effects on inducing parasite neutralizing activity, memory T cell response, and reducing parasite burden compared to single VLP vaccination. Lower levels of inflammatory cytokines (IFN-gamma, IL-6) and apoptosis responses were observed with VLP vaccine combination after challenge. These results suggest that VLP vaccines presenting both T. gondii ROP18 and MIC8 antigens confer enhanced protection compared to a single VLPs vaccine, and VLP platforms could be developed as potential vaccines against toxoplasmosis. (C) 2018 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据